Miller Steve (CIK 0001402535)

Latest company ownership

CPRX - CATALYST PHARMACEUTICALS, INC.
Role: Chief Op. & Scientific Officer
Shares held
1,076,197
Last filed at
Nov 24, 2025
Confidence Score
43.8
2025Q4
Confidence Score History
2012Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Aug 26, 2025 Aug 28, 2025 CATALYST PHARMACEUTICALS, INC. Chief Op. & Scientific Officer Sell 17.5 -115,000 -10.80% ✗ $2.3M
Dec 9, 2024 Dec 11, 2024 CATALYST PHARMACEUTICALS, INC. Chief Op. & Scientific Officer Sell 17.5 -50,000 -6.78% ✗ $1.1M
Aug 20, 2024 Aug 22, 2024 CATALYST PHARMACEUTICALS, INC. Chief Op. & Scientific Officer Sell 17.5 -150,000 -18.18% ✗ $3.1M
Dec 5, 2023 Dec 7, 2023 CATALYST PHARMACEUTICALS, INC. Chief Op. & Scientific Officer Sell 40.0 -40,000 -5.82% ✗ $569.6K
Nov 21, 2022 Nov 23, 2022 CATALYST PHARMACEUTICALS, INC. COO Sell 17.5 -100,000 -15.30% ✗ $1.6M
Sep 13, 2022 Sep 15, 2022 CATALYST PHARMACEUTICALS, INC. COO Sell 17.5 -107,933 -14.17% ✗ $1.8M
Aug 18, 2022 Aug 19, 2022 CATALYST PHARMACEUTICALS, INC. COO Sell 37.5 -150,000 -8.96% ✗ $2M
Aug 25, 2021 Aug 26, 2021 CATALYST PHARMACEUTICALS, INC. COO Sell 40.0 -80,000 -9.74% ✗ $444.6K
Aug 13, 2021 Aug 17, 2021 CATALYST PHARMACEUTICALS, INC. COO Sell 42.5 -40,963 -5.52% ✗ $249.4K
Jan 11, 2016 Jan 12, 2016 CATALYST PHARMACEUTICALS, INC. COO Buy 78.8 +7,933 1.76% ✗ $14.3K
Jun 4, 2014 Jun 4, 2014 CATALYST PHARMACEUTICALS, INC. COO Buy 95.0 +100,000 87.14% ✗ $217K
Jul 3, 2012 Jul 5, 2012 CATALYST PHARMACEUTICALS, INC. COO Buy 91.3 +40,000 53.51% ✗ $22K